Evidence map›Paper›PMID 35646945›Full record

ArticleFrontiers in medicine2022

Prognostic Significance of PD-L1 Expression and Standardized Uptake Values in the Primary Lesions of Stage IV Adenocarcinoma Lung Cancer.

Bui Tien Cong, Pham Cam Phuong, Pham-Van Thai, Vu-Le Thuong, Nguyen Quang Hung, Dong-Thi Hang, Hoang Anh Tuan, Doan Minh Khuy, Pham-Van Tuyen, Nguyen Minh Duc

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bui Tien CongDepartment of Nuclear Medicine, Ha Noi Medical University, Hanoi, Vietnam.
Pham Cam PhuongDepartment of Nuclear Medicine, Ha Noi Medical University, Hanoi, Vietnam.
Pham-Van ThaiDepartment of Nuclear Medicine, Ha Noi Medical University, Hanoi, Vietnam.
Vu-Le ThuongDepartment of Nuclear Medicine, Ha Noi Medical University, Hanoi, Vietnam.
Nguyen Quang HungNuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam.
Dong-Thi HangDepartment of Examination, Bach Mai Hospital, Hanoi, Vietnam.
Hoang Anh TuanPathology and Cytology Center, Bach Mai Hospital, Hanoi, Vietnam.
Doan Minh KhuyPathology and Cytology Center, Bach Mai Hospital, Hanoi, Vietnam.
Pham-Van TuyenPathology and Cytology Center, Bach Mai Hospital, Hanoi, Vietnam.
Nguyen Minh DucDepartment of Radiology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study evaluated the prognostic ability of Methods: In total, 86 patients with stage IV adenocarcinoma lung cancer underwent Results: The average age was 62.23 ± 9.51 years, and men and women represented 67.4% and 32.6% of the population, respectively. The Conclusions: SUV

Indexed as

adenocarcinomaFDG PET/CTlung cancerPD-L1predictionstage IVSUVmax

Identifiers

PMID35646945
PMCPMC9137395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.